These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 27553742

  • 1. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
    Linxweiler M, Bochen F, Schick B, Wemmert S, Al Kadah B, Greiner M, Hasenfus A, Bohle RM, Juhasz-Böss I, Solomayer EF, Takacs ZF.
    BMC Cancer; 2016 Aug 23; 16(1):676. PubMed ID: 27553742
    [Abstract] [Full Text] [Related]

  • 2. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
    Wright TC, Compagno J, Romano P, Grazioli V, Verma Y, Kershnar E, Tafas T, Kilpatrick MW.
    Am J Obstet Gynecol; 2015 Jul 23; 213(1):51.e1-51.e8. PubMed ID: 25659466
    [Abstract] [Full Text] [Related]

  • 3. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F, Adisurya H, Wemmert S, Lerner C, Greiner M, Zimmermann R, Hasenfus A, Wagner M, Smola S, Pfuhl T, Bozzato A, Al Kadah B, Schick B, Linxweiler M.
    Oncotarget; 2017 Jan 17; 8(3):4922-4934. PubMed ID: 28002801
    [Abstract] [Full Text] [Related]

  • 4. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F, Espinet B, Corzo C, Muñoz R, Bellosillo B, Lloveras B, Pijuan L, Gimeno J, Salido M, Solé F, Carreras R, Serrano S.
    Hum Pathol; 2009 Oct 17; 40(10):1474-8. PubMed ID: 19540557
    [Abstract] [Full Text] [Related]

  • 5. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
    Seppo A, Jalali GR, Babkowski R, Symiakaki H, Rodolakis A, Tafas T, Tsipouras P, Kilpatrick MW.
    Gynecol Oncol; 2009 Jul 17; 114(1):80-3. PubMed ID: 19394683
    [Abstract] [Full Text] [Related]

  • 6. HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.
    Regauer S, Reich O, Kashofer K.
    Am J Surg Pathol; 2022 Feb 01; 46(2):147-158. PubMed ID: 34387215
    [Abstract] [Full Text] [Related]

  • 7. EGFR protein expression and gene amplification in squamous intraepithelial lesions and squamous cell carcinomas of the cervix.
    Li Q, Tang Y, Cheng X, Ji J, Zhang J, Zhou X.
    Int J Clin Exp Pathol; 2014 Feb 01; 7(2):733-41. PubMed ID: 24551297
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH, Theelen W, Hommelberg PP, Kamps MA, Herrington CS, Morrison LE, Speel EJ, Smedts F, Ramaekers FC.
    J Pathol; 2006 Dec 01; 210(4):412-9. PubMed ID: 17054308
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
    Sui W, Ou M, Dai Y, Chen J, Lan H, Yan Q, Huang H.
    Int J Gynecol Cancer; 2009 Nov 01; 19(8):1303-6. PubMed ID: 20009881
    [Abstract] [Full Text] [Related]

  • 14. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
    Jung V, Kindich R, Kamradt J, Jung M, Müller M, Schulz WA, Engers R, Unteregger G, Stöckle M, Zimmermann R, Wullich B.
    Mol Cancer Res; 2006 Mar 01; 4(3):169-76. PubMed ID: 16547154
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
    Heselmeyer-Haddad K, Janz V, Castle PE, Chaudhri N, White N, Wilber K, Morrison LE, Auer G, Burroughs FH, Sherman ME, Ried T.
    Am J Pathol; 2003 Oct 01; 163(4):1405-16. PubMed ID: 14507648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
    Koeneman MM, Ovestad IT, Janssen EAM, Ummelen M, Kruitwagen RFPM, Hopman AH, Kruse AJ.
    Pathol Oncol Res; 2019 Apr 01; 25(2):549-557. PubMed ID: 30361910
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
    Gao L, Zhu Y, Liu SP, Gao Y, Zhu MH.
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb 01; 40(2):104-7. PubMed ID: 21426806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.